Endologix (ELGX) Misses Q1 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. BIIB
8. CMG
9. KLAC
10. ETSY

Go back to Endologix (ELGX) Misses Q1 EPS by 1c

Endologix Reports Results for the First Quarter 2016

May 9, 2016 4:07 PM EDT

IRVINE, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ: ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three months ended March 31, 2016.

John McDermott, Endologix Chairman and Chief Executive Officer, said, In the first quarter we completed our merger with TriVascular and got off to a great start with the integration of the companies. Revenue was ahead of our expectations due to continued Nellix sales growth in international markets, a strong start to the AFX2 launch in the U.S. and lower than anticipated disruption from... More